Revenue: The sum of all revenue fields included for a company's operating activities.
Agios Pharmaceuticals, Inc. (AGIO) had Revenue of $20.75M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$20.75M |
$-99.11M |
|
$1.32M |
|
$19.43M |
|
$130.77M |
|
$-110.03M |
|
$10.91M |
|
$-99.11M |
|
$-99.11M |
|
$-99.11M |
|
$-99.11M |
|
$-99.11M |
|
$-99.11M |
|
$-110.03M |
|
$-109.81M |
|
58.78M |
|
58.78M |
|
$-1.69 |
|
$-1.69 |
|
| Balance Sheet Financials | |
$834.84M |
|
$10.57M |
|
$350.15M |
|
$1.18B |
|
$58.84M |
|
-- |
|
$17.03M |
|
$75.88M |
|
$1.11B |
|
$1.11B |
|
$1.11B |
|
59.34M |
|
| Cash Flow Statement Financials | |
$-118.92M |
|
$141.31M |
|
$2.08M |
|
$89.13M |
|
$113.60M |
|
$24.47M |
|
$15.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
93.64% |
|
-530.34% |
|
-530.34% |
|
-- |
|
-477.74% |
|
-477.74% |
|
$-119.69M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.04 |
|
1.29 |
|
69.98 |
|
-8.94% |
|
-8.94% |
|
-8.36% |
|
-8.94% |
|
$18.69 |
|
$-2.04 |
|
$-2.02 |
|